EPISODE · Sep 26, 2024 · 43 MIN
46. Jonny Imerman | How He Started a Cancer Network 15,000+ Strong
from Permission To Shine · host Andrew Namanny
Jonny Imerman is the Co-Founder of Imerman Angels, a global network of 15,000 cancer survivors. After battling testicular cancer in his 20s, Jonny felt compelled to create a platform where individuals battling cancer can connect 1:1 with a mentor who has faced the same diagnosis. Additionally, he co-founded CLOZTALK (pronounced "Clothes Talk"), where they are building brand awareness for over 500 nonprofits. In this episode, we discuss: Living a life of purpose and fulfillment How cancer turned him into a minimalist His emphasis on diet as it's the #1 contributor to cancer diagnoses Daily meditation practices Life in New York City Please enjoy this insightful conversation with Jonny Imerman. I know you’ll love it! Feedback & Sponsorship Opportunities: [email protected] Imerman LinkedIn: Jonny Imerman LinkedInAndrew Namanny LinkedIn: Andrew Namanny LinkedIn
What this episode covers
Jonny Imerman is the Co-Founder of Imerman Angels, a global network of 15,000 cancer survivors. After battling testicular cancer in his 20s, Jonny felt compelled to create a platform where individuals battling cancer can connect 1:1 with a mentor who has faced the same diagnosis. Additionally, he co-founded CLOZTALK (pronounced "Clothes Talk"), where they are building brand awareness for over 500 nonprofits. In this episode, we discuss: Living a life of purpose and fulfillment How cancer turned him into a minimalist His emphasis on diet as it's the #1 contributor to cancer diagnoses Daily meditation practices Life in New York City Please enjoy this insightful conversation with Jonny Imerman. I know you’ll love it! Feedback & Sponsorship Opportunities: [email protected] Imerman LinkedIn: Jonny Imerman LinkedInAndrew Namanny LinkedIn: Andrew Namanny LinkedIn
NOW PLAYING
46. Jonny Imerman | How He Started a Cancer Network 15,000+ Strong
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m